Cargando…

Noradrenergic therapies for apathy in Alzheimer’s disease?

Detalles Bibliográficos
Autor principal:	Husain, Masud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872223/ https://www.ncbi.nlm.nih.gov/pubmed/36600570 http://dx.doi.org/10.1136/jnnp-2022-330824

Ejemplares similares

Apathy in Alzheimer's disease
por: Nobis, Lisa, et al.
Publicado: (2018)

Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes
por: Hezemans, Frank H., et al.
Publicado: (2022)

Distinct Subtypes of Apathy Revealed by the Apathy Motivation Index
por: Ang, Yuen-Siang, et al.
Publicado: (2017)

Are there distinct dimensions of apathy? The argument for reappraisal
por: Dickson, Shannon S., et al.
Publicado: (2022)

Brain mechanisms underlying apathy
por: Le Heron, Campbell, et al.
Publicado: (2019)

Noradrenergic dysfunction in Alzheimer's disease
por: Gannon, Mary, et al.
Publicado: (2015)

An Update on Apathy in Alzheimer’s Disease
por: Dolphin, Helena, et al.
Publicado: (2023)

Reward sensitivity and action in Parkinson’s disease patients with and without apathy
por: Muhammed, Kinan, et al.
Publicado: (2021)

Individual differences in empathy are associated with apathy-motivation
por: Lockwood, Patricia L., et al.
Publicado: (2017)

Characterization of reward and effort mechanisms in apathy
por: Bonnelle, Valerie, et al.
Publicado: (2015)

Individual Differences in Premotor Brain Systems Underlie Behavioral Apathy
por: Bonnelle, Valerie, et al.
Publicado: (2016)

Assessment of apathy in neurological patients using the Apathy Motivation Index caregiver version
por: Klar, Verena S., et al.
Publicado: (2021)

The relationship between apathy and impulsivity in large population samples
por: Petitet, Pierre, et al.
Publicado: (2021)

Differential impact of behavioral, social, and emotional apathy on Parkinson's disease
por: Ang, Yuen‐Siang, et al.
Publicado: (2018)

Dying-back of ascending noradrenergic projections in Parkinson’s disease
por: Helmich, Rick C, et al.
Publicado: (2021)

Apathy in Alzheimer's Disease: Any Effective Treatment?
por: Rea, Raffaele, et al.
Publicado: (2014)

Brain Perfusion Correlates of Apathy in Alzheimer's Disease
por: Jeong, Hyeonseok, et al.
Publicado: (2018)

Altered reward processing underpins emotional apathy in dementia
por: Wong, Stephanie, et al.
Publicado: (2022)

Apathy, but not depression, predicts all-cause dementia in cerebral small vessel disease
por: Tay, Jonathan, et al.
Publicado: (2020)

Dissociable behavioural signatures of co-existing impulsivity and apathy in decision-making
por: Petitet, Pierre, et al.
Publicado: (2022)

Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders
por: Lanctôt, Krista L., et al.
Publicado: (2023)

Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson’s disease
por: Muhammed, Kinan, et al.
Publicado: (2016)

Pathological Increases in Neuronal Hyperactivity in Selective Cholinergic and Noradrenergic Pathways May Limit the Efficacy of Amyloid-β-Based Interventions in Mild Cognitive Impairment and Alzheimer’s Disease
por: Pomara, Nunzio, et al.
Publicado: (2018)

Behavioral, Emotional and Social Apathy in Alcohol-Related Cognitive Disorders
por: van Dorst, Maud E. G., et al.
Publicado: (2021)

Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson’s disease
por: Le Heron, Campbell, et al.
Publicado: (2018)

Prosocial apathy for helping others when effort is required
por: Lockwood, Patricia L., et al.
Publicado: (2017)

A Key Noradrenergic Brainstem-Mesolimbic Circuit: Resilience to Social Stress
por: Zhang, Hongxing, et al.
Publicado: (2019)

Towards Astroglia-based Noradrenergic Hypothesis of Alzheimer’s Disease
por: Leanza, Giampiero, et al.
Publicado: (2022)

Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies
por: Slater, Cody, et al.
Publicado: (2021)

Apathy in the Elderly: From Assessment to Treatment
por: Leroi, Iracema, et al.
Publicado: (2012)

Apathy, cognitive function and motor function in Alzheimer's disease
por: Hernandez, Salma S. Soleman, et al.
Publicado: (2012)

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate
por: van Dyck, Christopher H., et al.
Publicado: (2020)

Dopamine reverses reward insensitivity in apathy following globus pallidus lesions
por: Adam, Robert, et al.
Publicado: (2013)

Degenerative alterations in noradrenergic neurons of the locus coeruleus in Alzheimer's disease
por: Liu, Lihua, et al.
Publicado: (2013)

Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
por: Peterson, Andrew C., et al.
Publicado: (2018)

New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease
por: David, Michael, et al.
Publicado: (2022)

Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
por: De Waele, Ségolène, et al.
Publicado: (2022)

Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
por: Pinder, Roger M
Publicado: (2005)

Dysfunctional effort-based decision-making underlies apathy in genetic cerebral small vessel disease
por: Le Heron, Campbell, et al.
Publicado: (2018)

Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment
por: Jacus, Jean‐Pierre
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3182sbtbkca75aoknd5ec0pg8p